Cargando…

A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma

Recent studies suggested that RNA binding proteins (RBPs) were related to the tumorigenesis and progression of glioma. This study was conducted to identify prognostic RBPs of glioblastoma (GBM) and construct an RBP signature to predict the prognosis of GBM. Univariate Cox regression analysis was car...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Qian-Rong, Li, Jian-Wen, Pan, Xin-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191310/
https://www.ncbi.nlm.nih.gov/pubmed/35049227
http://dx.doi.org/10.1097/MD.0000000000028065
_version_ 1784725984378880000
author Huang, Qian-Rong
Li, Jian-Wen
Pan, Xin-Bin
author_facet Huang, Qian-Rong
Li, Jian-Wen
Pan, Xin-Bin
author_sort Huang, Qian-Rong
collection PubMed
description Recent studies suggested that RNA binding proteins (RBPs) were related to the tumorigenesis and progression of glioma. This study was conducted to identify prognostic RBPs of glioblastoma (GBM) and construct an RBP signature to predict the prognosis of GBM. Univariate Cox regression analysis was carried out to identify the RBPs associated with overall survival of GBM in the The Cancer Genome Atlas (TCGA), GSE16011, and Repository for Molecular Brain Neoplasia data (Rembrandt) datasets, respectively. Overlapping RBPs from the TCGA, GSE16011, and Rembrandt datasets were selected. The biological role of prognostic RBPs was assessed by Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and protein–protein interaction analyses. Least absolute shrinkage and selection operator regression analysis and multivariate Cox regression analysis were used to construct an RBP-related risk signature. The prognostic value of RBP signature was measured by Kaplan–Meier method and time-dependent receiver operating characteristic curve. A nomogram based on independent prognostic factors was established to predict survival for GBM. The CGGA cohort was used as the validation cohort for external validation. This study identified 27 RBPs associated with the prognosis of GBM and constructed a 6-RPBs signature. Kaplan–Meier curves suggested that high-risk score was associated with a poor prognosis. Area under the curve of 1-, 3-, and 5-year overall survival was 0.618, 0.728, and 0.833 for TCGA cohort, 0.655, 0.909, and 0.911 for GSE16011 cohort, and 0.665, 0.792, and 0.781 for Rembrandt cohort, respectively. A nomogram with 4 parameters (age, chemotherapy, O(6)-methylguanine-DNA methyltransferase promoter status, and risk score) was constructed. The calibration curve showed that the nomogram prediction was in good agreement with the actual observation. The 6-RBPs signature could effectively predict the prognosis of GBM, and our findings supplemented the prognostic index of GBM to a certain extent.
format Online
Article
Text
id pubmed-9191310
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-91913102022-06-13 A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma Huang, Qian-Rong Li, Jian-Wen Pan, Xin-Bin Medicine (Baltimore) 5700 Recent studies suggested that RNA binding proteins (RBPs) were related to the tumorigenesis and progression of glioma. This study was conducted to identify prognostic RBPs of glioblastoma (GBM) and construct an RBP signature to predict the prognosis of GBM. Univariate Cox regression analysis was carried out to identify the RBPs associated with overall survival of GBM in the The Cancer Genome Atlas (TCGA), GSE16011, and Repository for Molecular Brain Neoplasia data (Rembrandt) datasets, respectively. Overlapping RBPs from the TCGA, GSE16011, and Rembrandt datasets were selected. The biological role of prognostic RBPs was assessed by Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and protein–protein interaction analyses. Least absolute shrinkage and selection operator regression analysis and multivariate Cox regression analysis were used to construct an RBP-related risk signature. The prognostic value of RBP signature was measured by Kaplan–Meier method and time-dependent receiver operating characteristic curve. A nomogram based on independent prognostic factors was established to predict survival for GBM. The CGGA cohort was used as the validation cohort for external validation. This study identified 27 RBPs associated with the prognosis of GBM and constructed a 6-RPBs signature. Kaplan–Meier curves suggested that high-risk score was associated with a poor prognosis. Area under the curve of 1-, 3-, and 5-year overall survival was 0.618, 0.728, and 0.833 for TCGA cohort, 0.655, 0.909, and 0.911 for GSE16011 cohort, and 0.665, 0.792, and 0.781 for Rembrandt cohort, respectively. A nomogram with 4 parameters (age, chemotherapy, O(6)-methylguanine-DNA methyltransferase promoter status, and risk score) was constructed. The calibration curve showed that the nomogram prediction was in good agreement with the actual observation. The 6-RBPs signature could effectively predict the prognosis of GBM, and our findings supplemented the prognostic index of GBM to a certain extent. Lippincott Williams & Wilkins 2021-12-03 /pmc/articles/PMC9191310/ /pubmed/35049227 http://dx.doi.org/10.1097/MD.0000000000028065 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 5700
Huang, Qian-Rong
Li, Jian-Wen
Pan, Xin-Bin
A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma
title A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma
title_full A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma
title_fullStr A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma
title_full_unstemmed A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma
title_short A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma
title_sort novel risk signature with 6 rna binding proteins for prognosis prediction in patients with glioblastoma
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191310/
https://www.ncbi.nlm.nih.gov/pubmed/35049227
http://dx.doi.org/10.1097/MD.0000000000028065
work_keys_str_mv AT huangqianrong anovelrisksignaturewith6rnabindingproteinsforprognosispredictioninpatientswithglioblastoma
AT lijianwen anovelrisksignaturewith6rnabindingproteinsforprognosispredictioninpatientswithglioblastoma
AT panxinbin anovelrisksignaturewith6rnabindingproteinsforprognosispredictioninpatientswithglioblastoma
AT huangqianrong novelrisksignaturewith6rnabindingproteinsforprognosispredictioninpatientswithglioblastoma
AT lijianwen novelrisksignaturewith6rnabindingproteinsforprognosispredictioninpatientswithglioblastoma
AT panxinbin novelrisksignaturewith6rnabindingproteinsforprognosispredictioninpatientswithglioblastoma